A tender offer or secondary sale.
A tender offer is a rare thing: a chance to turn some of the paper into real money before any exit. What you keep depends on a few decisions made in a narrow window.
Concentration, QSBS, and next year’s tax bill.
Selling into a tender is a chance to cut the concentration that’s quietly become most of your net worth. But how much you sell, and when, affects whether your shares still qualify for QSBS, the exclusion that can shield a large piece of the gain from federal tax, and it sets the tax bill you’ll face next April.
We work the window in the same order we work everything else.
Protect. First we look at what’s at stake. Whether your shares qualify for QSBS and what a sale does to it, the tax the sale would create, and how concentrated you’d still be afterward.
Subtract, then align. We strip the decision down to what matters and line up your tax picture, your concentration target, and your goals, so the sale serves the plan instead of a deadline.
Build. Then we size the actual decision. How much to sell to meaningfully reduce risk, what to do with the proceeds, and how to stage it so the tax and the QSBS treatment work in your favor.
The Plan is $5,000 flat, built for delivery within 30 days of kickoff, and backed by the Plan Promise: a full refund, for any reason, if you ask in writing within 30 days after delivery. You keep the plan.
See what’s included and how pricing works →How much should I sell?
Enough to meaningfully reduce a concentration that could undo years of work, balanced against the tax it creates and any QSBS treatment you’d want to preserve. There’s no single right number, which is why it’s worth sizing against your actual picture rather than a rule of thumb.
Will selling now affect my QSBS?
It can. QSBS turns on holding period and other rules, and selling too early or in the wrong way can reduce or eliminate a valuable exclusion, or change the planning path for it. Worth confirming before the sale, not discovering after.